News & Articles

We are seeking a dedicated Technician to join our Operations team to work on the OSTEOproDENT project. This fundamental role is focused on supporting the technical aspects of research and development, particularly in the production of rhBMP6 for our novel bone-healing drug. The Technician will be involved in hands-on technical work, maintaining laboratory equipment, assisting in experiments, and ensuring the smooth operation of our research and manufacturing processes. Key Responsibilities Technical Support: Provide technical assistance in laboratory or manufacturing settings, supporting various research and production activities Equipment Maintenance: Responsible for the maintenance, calibration, and troubleshooting of laboratory or manufacturing equipment to ensure optimal performance Experiment Assistance: Assist scientists and engineers in setting up and conducting experiments, including preparing samples and reagents Data Collection: Collect and record experimental or production data accurately for further analysis. Inventory Management: Manage and maintain inventory of laboratory supplies, chemicals, and equipment Safety Compliance: Adhere to all safety guidelines and procedures, ensuring a safe working environment Collaborative Work: Work closely with other team members, contributing to collaborative projects and supporting the overall goals of the department Reporting: reports to a laboratory manager, senior scientist, or head of the manufacturing department. Qualifications Education: Associate degree or technical certification in a relevant field (e.g., Biology, Chemistry, Biotechnology, Engineering). Experience: Previous experience as a technician in a laboratory or manufacturing environment, preferably in the biotechnology or pharmaceutical industry. Skills: Good technical and hands-on skills, attention to detail, ability to follow complex instructions, and strong organizational abilities. As a technician, you will play a crucial role in the practical aspects of our research and production processes. Your technical expertise and support are vital in ensuring the efficiency, accuracy, and safety of our operations, contributing significantly to the advancement of our innovative drug development projects. If you are eager to contribute to groundbreaking research in a dynamic laboratory environment, we encourage you to send your application to info@genera-research.com. Please note that only EU residents are eligible.

We are seeking two dedicated Research Associates to join our Operations division team, to work on the OSTEOproDENT project. Your primary responsibility will be hands-on laboratory work, driving innovation: Develop and apply aseptic techniques on cell culture; inoculation, feeding, sampling, recovery, and purification processes on a small scale (upstream and downstream process). Experience in small-scale (shaking flasks) and single-use bioreactors is considered a plus. Contributing directly to the research and production development of rhBMP6 for our novel bone-healing drug. Conducting various laboratory experiments, data collection, and analysis, and supporting the overall research objectives under the supervision of senior scientists Advancing our scientific understanding and development efforts for new drug therapies Providing hands-on support in the lab and contributing to the innovative research driving our drug development projects Combining technical skills with analytical capabilities plays a significant part in advancing our scientific objectives Support process development (perfusion and intensified fed-batch) at the bench and pilot scale. Responsibilities Experimental Conduct: Perform laboratory experiments following GMP standards and established protocols and methodologies related to bone regeneration research Data Collection and Analysis: Gather, record, and analyze experimental data, ensuring accuracy and reliability of results Lab Maintenance: Maintain laboratory equipment and supplies, ensuring a clean and safe working environment Research Support: Assist senior research staff in various aspects of projects, including sample preparation, reagent preparation, and maintaining lab notes and records Collaborative Work: Participate in research team meetings, contributing ideas and findings to advance project goals Literature Reviews: Stay informed of recent scientific advances and literature in bone regeneration and related areas Report Writing: Assist in preparing research reports, scientific papers, and presentations Reporting: Reports to a Senior Scientist or Project Lead in the R&D department. Requirements Education: Masters in biotechnology, Molecular Biology, Biochemistry, or a related scientific field. Experience: Experience in a pharmaceutical research laboratory, or biotechnology production process, with mandatory experience in working with bioreactors or conducting pharmaceutical research. Prior experience in bone regeneration research and recombinant protein manufacturing is an advantage. cGMP experience within biologics, pharmaceuticals, and/or vaccine manufacturing, including expertise in aseptic techniques, suspension cell culture processes, media/feed development, recovery, purification, bulk formulation, and aseptic environments. Experience in single-use bioreactor operations is a big advantage, including setup and process run on single-use bioreactors. Knowledge and hands-on experience in perfusion and intensified fed-batch processes are also considered as an advantage. Skills: Strong laboratory and pilot scale skills (recombinant protein expression; aseptic techniques on cell culture; inoculation, feeding, sampling, recovery, and purification processes on a small and pilot scale (upstream and downstream process), attention to detail, analytical thinking, effective communication, and the ability to work collaboratively in a research environment. Language: Proficiency in English, both written and spoken, at a minimum of B2 level The ideal candidate will have a proven track record of a deep understanding of upstream and downstream processes with mammalian cell culture and perfusion bioreactor development to produce clinical and commercial therapeutic proteins. This role is an excellent opportunity for individuals passionate about scientific research and development. If you are eager to contribute to groundbreaking research in a dynamic laboratory, we encourage you to send your application to info@genera-research.com. Please note that only EU residents are eligible.

Genera Research is proud to announce a significant milestone in the world of regenerative medicine with the successful recruitment of the first patient in Phase II of a clinical study. This study is focused on testing the efficacy, safety, and tolerability of Osteogrow (recombinant human bone morphogenetic protein 6 in autologous blood coagulum) in alveolar ridge regeneration following tooth extraction. The clinical site for this groundbreaking study is the prestigious Stomatology Faculty of the University of Zagreb.

In medical breakthroughs, the OSTEOproSPINE project, with Genera Research as a clinical trials sponsor and a consortium partner, has been spotlighted by CORDIS in the ‘Results in Brief’ section of the European Commission’s website. This recognition underscores the significant strides in developing Osteogrow, a novel treatment promising to revolutionize bone regeneration and relieve millions suffering from chronic lumbar back pain in the EU. The phase II clinical trial, backed by Genera Research, has shown that Osteogrow can effectively stabilize the lumbar spine and mitigate pain recurrence. Such innovative advancements exemplify our commitment to pioneering drug discovery and development. As we progress with the final Phase III clinical trials, we are inspired by the CORDIS selection to continue our mission of delivering life-changing treatments to the market. The anticipated introduction of Osteogrow-C in the EU market by 2028 is set to substantially impact patients' quality of life, making a significant milestone for Genera Research and the medical community at large​​.

The Symposium on Regenerative Medicine - New Platforms and Potentials, hosted by the Center of Excellence for Reproductive and Regenerative Medicine (CERRM) – Subunit for Regenerative Medicine, took place at the Amadria Park Hotel Royal in Opatija from October 23-25, 2023. This event was a collaborative effort, with Genera Research as a partner, featuring guest lecturers from its esteemed team.

On 25.10.2022 Genera Research COO Dora Adanić had the privilege to be a guest lecturer at Libertas International University in Zagreb on the Technology and Innovation Management course under the guidance of doc. Dr.sc. Helena Šlogar. The lecture topic was "Development and clinical testing of Osteogrow, the first Croatian drug for global use".

Genera Research was one of the sponsors of the 13th International BMP Conference 2022 held in Dubrovnik, Croatia, from the 8th to the 12th of October.

On June 19th, 2018 at the “Let the Stars Shine” exhibition in the European Parliament in Brussels project OSTEOGROW, coordinated by the University of Zagreb School of Medicine, was presented as one of five most significant Croatian projects financed by the European Union.

After the common cold, it is the second most common medical condition, and in more severe cases, surgery is usually perfomed.

The University of Zagreb School of Medicine is the head of the OsteoProSpine project, in which 12 partner institutions from six countries participate.

The drug OSTEOGROW is the first innovative drug in independent Croatia and the second after the very successful Sumamed, which is entirely the product of Croatian scientists. A little blood, a little bone protein and here is a medicine for bone regeneration and healing! The Croatian sensation of world scale in pharmaceuticals is called OSTEOGROW, and the results of the clinical trials conducted so far say that the first drug created in the Croatian state could become an indispensable aid to patients with bone healing problems and those who need to replace a missing part of the bone already in two to three years.